Richard Stephen bought ANIK
June 18, 2026 · Form 4 insider transaction
Richard Stephen bought 10,402 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,402
Price
$0.00
Total value
N/A
InsiderRichard Stephen
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after58,273
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. The RSUs vest in full on the earlier of the 2027 annual meeting of the Company's stockholders or June 18, 2027.